Level Wealth Management »

BioMarin Pharmaceutical shares owned by Level Wealth Management

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Level Wealth Management from 13F filings

Historical chart of Level Wealth Management investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Level Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Level Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $491k 9.1k 54.16
2025-06-30 $498k 9.1k 54.97
2025-03-31 $641k 9.1k 70.69
2024-12-31 $627k 9.5k 65.73

More positions owned by Level Wealth Management

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Ishares Tr National Mun Etf (MUB)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Ishares Tr Core Msci Eafe (IEFA)
Microsoft Corporation (MSFT)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Instl Index 0-3 Mo Treas Bil (VBIL)

View all positions for Level Wealth Management

Top funds holding BioMarin Pharmaceutical

BlackRock
Vanguard Group
PRIMECAP Management Company
Dodge & Cox
State Street Corporation
Viking Global Investors
AQR Capital Management
Geode Capital Management
Millennium Management
Capital Research Global Investors
Morgan Stanley
Goldman Sachs Group
Dimensional Fund Advisors
Renaissance Technologies
Northern Trust

View all funds holding BioMarin Pharmaceutical